Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: Effects of dexamethasone

Journal of Infectious Diseases

Volumn 192, Issue 12, 2005, Pages 2054-2058

  Rock, R Bryan ^a   Hu, Shuxian ^a   Gekker, Genya ^a   Sheng, Wen S ^a   May, Barbara ^b   Kapur, Vivek ^b   Peterson, Phillip K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE;

ARTICLE; ASTROCYTE; DRUG EFFECT; HUMAN; HUMAN TISSUE; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; MICROGLIA; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS H37RV; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK BENEFIT ANALYSIS; TARGET CELL; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DEXAMETHASONE; FEMALE; HUMANS; MICE; MICROGLIA; MYCOBACTERIUM TUBERCULOSIS;

EID: 28844454323     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/498165     Document Type: Article

References (15)

1. Dye C. Global burden of tuberculosis. JAMA 1999; 282:677-86.
2. Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 1990; 141:347-51.
3. Girgis NI, Sultan Y, Farid Z, et al. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 1998; 58:28-34.
4. Farer LS, Lowell AM, Meador MP. Extrapulmonary tuberculosis in the United States. Am J Epidemiol 1979; 109:205-17.
5. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992; 326:668-72.
6. Kaojarern S, Supmonchai K, Phuapradit P, Mokkhavesa C, Krittiyanunt S. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Clin Pharmacol Ther 1991; 49:6-12.
7. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev 2000; 3:CD002244.
8. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351:1741-51.
9. American Thoracic Society, Center for Disease Control and Prevention, and Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52:1-77.
10. Leonard JM, Des Prez RM. Tuberculous meningitis. Infect Dis Clin North Am 1990; 4:769-87.
11. Rock RB, Gekker G, Hu S, et al. Role of microglia in central nervous system infections. Clin Microbiol Rev 2004; 17:942-64.
12. Curto M, Reali C, Palmieri G, et al. Inhibition of cytokine expression in human microglia infected by virulent and non-virulent mycobacteria. Neurochem Int 2004; 44:381-92.
13. Peterson PK, Gekker G, Hu S, et al. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immun 1995; 63:1598-602.
14. Peterson PK, Hu S, Salak-Johnson J, Molitor TW, Chao CC. Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis 1997; 175:478-81.
15. Bonecini-Almeida MG, Chitale S, Boutsikakis I, et al. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. J Immunol 1998; 160:4490-9.